Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $4.40 and traded as high as $4.47. Evotec shares last traded at $4.39, with a volume of 57,649 shares.
Evotec Stock Down 3.9 %
The company has a market cap of $1.39 billion, a P/E ratio of 10.29 and a beta of 0.98. The firm’s 50-day simple moving average is $4.40 and its 200 day simple moving average is $4.20. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
See Also
- Five stocks we like better than Evotec
- What Makes a Stock a Good Dividend Stock?
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- What is the Dow Jones Industrial Average (DJIA)?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- How to Buy Cheap Stocks Step by Step
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
